Assura Past Earnings Performance
Past criteria checks 0/6
Assura's earnings have been declining at an average annual rate of -38.4%, while the Health Care REITs industry saw earnings declining at 0.08% annually. Revenues have been growing at an average rate of 9.2% per year.
Key information
-38.4%
Earnings growth rate
-39.3%
EPS growth rate
| Health Care REITs Industry Growth | 7.7% |
| Revenue growth rate | 9.2% |
| Return on equity | -2.0% |
| Net Margin | -18.3% |
| Next Earnings Update | 14 Nov 2024 |
Recent past performance updates
Recent updates
Shareholders Will Most Likely Find Assura Plc's (LON:AGR) CEO Compensation Acceptable
Jun 29
With EPS Growth And More, Assura (LON:AGR) Is Interesting
May 20Are Assura Plc's (LON:AGR) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 11Did Assura Plc (LON:AGR) Insiders Buy Up More Shares?
Jan 10Assura (LON:AGR) Has Compensated Shareholders With A Respectable 65% Return On Their Investment
Dec 14Assura Plc (LON:AGR) On An Uptrend: Could Fundamentals Be Driving The Stock?
Nov 18
Revenue & Expenses Breakdown
How Assura makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 158 | -29 | 14 | 0 |
| 31 Dec 23 | 155 | -98 | 14 | 0 |
| 30 Sep 23 | 153 | -168 | 14 | 0 |
| 30 Jun 23 | 152 | -144 | 14 | 0 |
| 31 Mar 23 | 150 | -119 | 14 | 0 |
| 31 Dec 22 | 148 | -1 | 13 | 0 |
| 30 Sep 22 | 146 | 117 | 13 | 0 |
| 30 Jun 22 | 142 | 137 | 13 | 0 |
| 31 Mar 22 | 137 | 156 | 12 | 0 |
| 31 Dec 21 | 133 | 145 | 11 | 0 |
| 30 Sep 21 | 128 | 134 | 10 | 0 |
| 30 Jun 21 | 125 | 121 | 11 | 0 |
| 31 Mar 21 | 121 | 108 | 12 | 0 |
| 31 Dec 20 | 118 | 97 | 12 | 0 |
| 30 Sep 20 | 116 | 86 | 13 | 0 |
| 30 Jun 20 | 114 | 83 | 12 | 0 |
| 31 Mar 20 | 112 | 79 | 10 | 0 |
| 31 Dec 19 | 110 | 81 | 10 | 0 |
| 30 Sep 19 | 108 | 83 | 10 | 0 |
| 30 Jun 19 | 105 | 84 | 9 | 0 |
| 31 Mar 19 | 102 | 84 | 9 | 0 |
| 31 Dec 18 | 99 | 60 | 9 | 0 |
| 30 Sep 18 | 96 | 36 | 9 | 0 |
| 30 Jun 18 | 91 | 54 | 8 | 0 |
| 31 Mar 18 | 86 | 72 | 8 | 0 |
| 31 Dec 17 | 81 | 99 | 8 | 0 |
| 30 Sep 17 | 76 | 127 | 8 | 0 |
| 30 Jun 17 | 74 | 111 | 7 | 0 |
| 31 Mar 17 | 71 | 95 | 7 | 0 |
| 31 Dec 16 | 69 | 65 | 7 | 0 |
| 30 Sep 16 | 66 | 34 | 7 | 0 |
| 30 Jun 16 | 64 | 31 | 7 | 0 |
| 31 Mar 16 | 61 | 28 | 8 | 0 |
| 31 Dec 15 | 59 | 42 | 8 | 0 |
| 30 Sep 15 | 57 | 56 | 8 | 0 |
| 30 Jun 15 | 54 | 47 | 7 | 0 |
| 31 Mar 15 | 51 | 37 | 6 | 0 |
| 30 Sep 14 | 45 | 28 | 6 | 0 |
| 30 Jun 14 | 42 | 26 | 6 | 0 |
| 31 Mar 14 | 40 | 24 | 6 | 0 |
Quality Earnings: AGR is currently unprofitable.
Growing Profit Margin: AGR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AGR is unprofitable, and losses have increased over the past 5 years at a rate of 38.4% per year.
Accelerating Growth: Unable to compare AGR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AGR is unprofitable, making it difficult to compare its past year earnings growth to the Health Care REITs industry (29.2%).
Return on Equity
High ROE: AGR has a negative Return on Equity (-1.96%), as it is currently unprofitable.